Inflammatory bowel disease and thromboembolic events: a c’lot to learn Article Swipe
Ana Catarina Carvalho
,
Juliana Pinho
,
Eugénia Cancela
,
Hugo Marcelo Vieira
,
Américo Silva
,
Paula Ministro
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1177/17562848221100626
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1177/17562848221100626
Background: Inflammatory bowel disease (IBD) is associated with a variety of extraintestinal manifestations including arterial and venous thromboembolism. Research evidences that IBD patients have about a 2- to 3-fold increase in the risk of venous thromboembolism when compared with the general population. Objectives: We intended to evaluate the coagulation parameters and the prevalence of thromboembolic events (TE) in IBD patients. It was also our aim to investigate the correlation between coagulation parameters and disease phenotype and activity in this population. Methods: This single center prospective observational study was performed between November 2016 and April 2020. The cohort included patients with 18 years of age or older, diagnosed with IBD and followed at a gastroenterology consultation, during a follow-up period of 36 months. Patients were evaluated in terms of IBD type, extent and disease behavior, clinical scores of IBD activity, medication, smoking history, family and personal history of TE, coagulation parameters, fecal calprotectin levels, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), hospitalization due to TE, IBD-related hospitalization or surgery, pregnancy, or diagnosis of malignancy. Results: The study included 149 IBD patients (67 males and 82 females). Coagulation parameters were similar in CD and UC patients and only plasminogen was increased in CD patients [97.4 (17.0) versus 91.6 (13.3), p = 0.035], when comparing with UC patients. The determined values were in the range of the reference values described in literature for the standard population. During the follow-up period, none of the patients experienced a TE that demanded hospitalization. Conclusion: In our study, acquired and inherited risk factors for TE and changes in coagulation parameters did not show to influence prothrombotic predisposition in IBD patients. As such, the clinical relevance of measuring coagulation parameters in this population is questionable. Trial Registry: NCT05162339 (ClinicalTrials.gov ID).
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/17562848221100626
- https://journals.sagepub.com/doi/pdf/10.1177/17562848221100626
- OA Status
- gold
- Cited By
- 4
- References
- 41
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4285140987
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4285140987Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/17562848221100626Digital Object Identifier
- Title
-
Inflammatory bowel disease and thromboembolic events: a c’lot to learnWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-01-01Full publication date if available
- Authors
-
Ana Catarina Carvalho, Juliana Pinho, Eugénia Cancela, Hugo Marcelo Vieira, Américo Silva, Paula MinistroList of authors in order
- Landing page
-
https://doi.org/10.1177/17562848221100626Publisher landing page
- PDF URL
-
https://journals.sagepub.com/doi/pdf/10.1177/17562848221100626Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://journals.sagepub.com/doi/pdf/10.1177/17562848221100626Direct OA link when available
- Concepts
-
Medicine, Internal medicine, Inflammatory bowel disease, Calprotectin, Population, Gastroenterology, Prospective cohort study, Erythrocyte sedimentation rate, Cohort, Family history, Ulcerative colitis, Disease, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2023: 2Per-year citation counts (last 5 years)
- References (count)
-
41Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4285140987 |
|---|---|
| doi | https://doi.org/10.1177/17562848221100626 |
| ids.doi | https://doi.org/10.1177/17562848221100626 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35651649 |
| ids.openalex | https://openalex.org/W4285140987 |
| fwci | 1.01936079 |
| type | article |
| title | Inflammatory bowel disease and thromboembolic events: a c’lot to learn |
| biblio.issue | |
| biblio.volume | 15 |
| biblio.last_page | 17562848221100626 |
| biblio.first_page | 17562848221100626 |
| topics[0].id | https://openalex.org/T10134 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9944999814033508 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Inflammatory Bowel Disease |
| topics[1].id | https://openalex.org/T10285 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9818999767303467 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2724 |
| topics[1].subfield.display_name | Internal Medicine |
| topics[1].display_name | Venous Thromboembolism Diagnosis and Management |
| topics[2].id | https://openalex.org/T12328 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9534000158309937 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Autoimmune and Inflammatory Disorders |
| is_xpac | False |
| apc_list.value | 2300 |
| apc_list.currency | USD |
| apc_list.value_usd | 2300 |
| apc_paid.value | 2300 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2300 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9591095447540283 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C126322002 |
| concepts[1].level | 1 |
| concepts[1].score | 0.7210171222686768 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[1].display_name | Internal medicine |
| concepts[2].id | https://openalex.org/C2778260677 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7098685503005981 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q917447 |
| concepts[2].display_name | Inflammatory bowel disease |
| concepts[3].id | https://openalex.org/C2778292693 |
| concepts[3].level | 4 |
| concepts[3].score | 0.6937577128410339 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q22328664 |
| concepts[3].display_name | Calprotectin |
| concepts[4].id | https://openalex.org/C2908647359 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6176551580429077 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[4].display_name | Population |
| concepts[5].id | https://openalex.org/C90924648 |
| concepts[5].level | 1 |
| concepts[5].score | 0.55189049243927 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[5].display_name | Gastroenterology |
| concepts[6].id | https://openalex.org/C188816634 |
| concepts[6].level | 2 |
| concepts[6].score | 0.47726863622665405 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2113324 |
| concepts[6].display_name | Prospective cohort study |
| concepts[7].id | https://openalex.org/C2778143017 |
| concepts[7].level | 2 |
| concepts[7].score | 0.45883268117904663 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q111208 |
| concepts[7].display_name | Erythrocyte sedimentation rate |
| concepts[8].id | https://openalex.org/C72563966 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4513610005378723 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[8].display_name | Cohort |
| concepts[9].id | https://openalex.org/C2781179581 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4201543927192688 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2857712 |
| concepts[9].display_name | Family history |
| concepts[10].id | https://openalex.org/C2780479503 |
| concepts[10].level | 3 |
| concepts[10].score | 0.41860824823379517 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1477 |
| concepts[10].display_name | Ulcerative colitis |
| concepts[11].id | https://openalex.org/C2779134260 |
| concepts[11].level | 2 |
| concepts[11].score | 0.383194237947464 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[11].display_name | Disease |
| concepts[12].id | https://openalex.org/C99454951 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[12].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9591095447540283 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/internal-medicine |
| keywords[1].score | 0.7210171222686768 |
| keywords[1].display_name | Internal medicine |
| keywords[2].id | https://openalex.org/keywords/inflammatory-bowel-disease |
| keywords[2].score | 0.7098685503005981 |
| keywords[2].display_name | Inflammatory bowel disease |
| keywords[3].id | https://openalex.org/keywords/calprotectin |
| keywords[3].score | 0.6937577128410339 |
| keywords[3].display_name | Calprotectin |
| keywords[4].id | https://openalex.org/keywords/population |
| keywords[4].score | 0.6176551580429077 |
| keywords[4].display_name | Population |
| keywords[5].id | https://openalex.org/keywords/gastroenterology |
| keywords[5].score | 0.55189049243927 |
| keywords[5].display_name | Gastroenterology |
| keywords[6].id | https://openalex.org/keywords/prospective-cohort-study |
| keywords[6].score | 0.47726863622665405 |
| keywords[6].display_name | Prospective cohort study |
| keywords[7].id | https://openalex.org/keywords/erythrocyte-sedimentation-rate |
| keywords[7].score | 0.45883268117904663 |
| keywords[7].display_name | Erythrocyte sedimentation rate |
| keywords[8].id | https://openalex.org/keywords/cohort |
| keywords[8].score | 0.4513610005378723 |
| keywords[8].display_name | Cohort |
| keywords[9].id | https://openalex.org/keywords/family-history |
| keywords[9].score | 0.4201543927192688 |
| keywords[9].display_name | Family history |
| keywords[10].id | https://openalex.org/keywords/ulcerative-colitis |
| keywords[10].score | 0.41860824823379517 |
| keywords[10].display_name | Ulcerative colitis |
| keywords[11].id | https://openalex.org/keywords/disease |
| keywords[11].score | 0.383194237947464 |
| keywords[11].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1177/17562848221100626 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S23481971 |
| locations[0].source.issn | 1756-283X, 1756-2848 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1756-283X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Therapeutic Advances in Gastroenterology |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_lineage_names | SAGE Publishing |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/17562848221100626 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Therapeutic Advances in Gastroenterology |
| locations[0].landing_page_url | https://doi.org/10.1177/17562848221100626 |
| locations[1].id | pmid:35651649 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Therapeutic advances in gastroenterology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35651649 |
| locations[2].id | pmh:oai:doaj.org/article:8f1c44914ee84e92b1ba41d7afcad1b6 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Therapeutic Advances in Gastroenterology, Vol 15 (2022) |
| locations[2].landing_page_url | https://doaj.org/article/8f1c44914ee84e92b1ba41d7afcad1b6 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:9149613 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Therap Adv Gastroenterol |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9149613 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5039236353 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6536-8381 |
| authorships[0].author.display_name | Ana Catarina Carvalho |
| authorships[0].countries | PT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210087844 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[0].institutions[0].id | https://openalex.org/I4210087844 |
| authorships[0].institutions[0].ror | https://ror.org/0025r1k74 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210087844 |
| authorships[0].institutions[0].country_code | PT |
| authorships[0].institutions[0].display_name | Centro Hospitalar Tondela-Viseu |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ana Catarina Carvalho |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[1].author.id | https://openalex.org/A5103135197 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-9935-8648 |
| authorships[1].author.display_name | Juliana Pinho |
| authorships[1].countries | PT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210087844 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[1].institutions[0].id | https://openalex.org/I4210087844 |
| authorships[1].institutions[0].ror | https://ror.org/0025r1k74 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210087844 |
| authorships[1].institutions[0].country_code | PT |
| authorships[1].institutions[0].display_name | Centro Hospitalar Tondela-Viseu |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Juliana Pinho |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[2].author.id | https://openalex.org/A5054027304 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Eugénia Cancela |
| authorships[2].countries | PT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210087844 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[2].institutions[0].id | https://openalex.org/I4210087844 |
| authorships[2].institutions[0].ror | https://ror.org/0025r1k74 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210087844 |
| authorships[2].institutions[0].country_code | PT |
| authorships[2].institutions[0].display_name | Centro Hospitalar Tondela-Viseu |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Eugénia Cancela |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[3].author.id | https://openalex.org/A5062982507 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Hugo Marcelo Vieira |
| authorships[3].countries | PT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210110056 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Public Health, Unidade de Saúde Pública ACeS Maia/Valongo, Porto, Portugal |
| authorships[3].institutions[0].id | https://openalex.org/I4210110056 |
| authorships[3].institutions[0].ror | https://ror.org/0208sdr22 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210110056 |
| authorships[3].institutions[0].country_code | PT |
| authorships[3].institutions[0].display_name | Administração Regional de Saúde de Lisboa e Vale do Tejo |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hugo Marcelo Vieira |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Public Health, Unidade de Saúde Pública ACeS Maia/Valongo, Porto, Portugal |
| authorships[4].author.id | https://openalex.org/A5072798586 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-4705-1492 |
| authorships[4].author.display_name | Américo Silva |
| authorships[4].countries | PT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210087844 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[4].institutions[0].id | https://openalex.org/I4210087844 |
| authorships[4].institutions[0].ror | https://ror.org/0025r1k74 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210087844 |
| authorships[4].institutions[0].country_code | PT |
| authorships[4].institutions[0].display_name | Centro Hospitalar Tondela-Viseu |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Américo Silva |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Viseu, Portugal |
| authorships[5].author.id | https://openalex.org/A5056740989 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2439-9522 |
| authorships[5].author.display_name | Paula Ministro |
| authorships[5].countries | PT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210087844 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Av. Rei D. Duarte, 3504-509 Viseu, Portugal |
| authorships[5].institutions[0].id | https://openalex.org/I4210087844 |
| authorships[5].institutions[0].ror | https://ror.org/0025r1k74 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210087844 |
| authorships[5].institutions[0].country_code | PT |
| authorships[5].institutions[0].display_name | Centro Hospitalar Tondela-Viseu |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Paula Ministro |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Gastroenterology, Centro Hospitalar Tondela-Viseu, E.P.E., Av. Rei D. Duarte, 3504-509 Viseu, Portugal |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.sagepub.com/doi/pdf/10.1177/17562848221100626 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Inflammatory bowel disease and thromboembolic events: a c’lot to learn |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10134 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9944999814033508 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Inflammatory Bowel Disease |
| related_works | https://openalex.org/W2075755922, https://openalex.org/W4211178974, https://openalex.org/W2083473937, https://openalex.org/W3174943467, https://openalex.org/W1546437617, https://openalex.org/W2087425189, https://openalex.org/W2467676092, https://openalex.org/W2154403103, https://openalex.org/W2043422462, https://openalex.org/W2378399001 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1177/17562848221100626 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S23481971 |
| best_oa_location.source.issn | 1756-283X, 1756-2848 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1756-283X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Therapeutic Advances in Gastroenterology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_lineage_names | SAGE Publishing |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/17562848221100626 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Therapeutic Advances in Gastroenterology |
| best_oa_location.landing_page_url | https://doi.org/10.1177/17562848221100626 |
| primary_location.id | doi:10.1177/17562848221100626 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S23481971 |
| primary_location.source.issn | 1756-283X, 1756-2848 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1756-283X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Therapeutic Advances in Gastroenterology |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_lineage_names | SAGE Publishing |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/17562848221100626 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Therapeutic Advances in Gastroenterology |
| primary_location.landing_page_url | https://doi.org/10.1177/17562848221100626 |
| publication_date | 2022-01-01 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2085455219, https://openalex.org/W2944723384, https://openalex.org/W2937406308, https://openalex.org/W2412688089, https://openalex.org/W2156615549, https://openalex.org/W2566264737, https://openalex.org/W2067626463, https://openalex.org/W2125139860, https://openalex.org/W2100924055, https://openalex.org/W2121098498, https://openalex.org/W2155476128, https://openalex.org/W2093529862, https://openalex.org/W2043024276, https://openalex.org/W3013197911, https://openalex.org/W3022423927, https://openalex.org/W2066968266, https://openalex.org/W2803074090, https://openalex.org/W2010352517, https://openalex.org/W2128099886, https://openalex.org/W2795784769, https://openalex.org/W2772365864, https://openalex.org/W2991330413, https://openalex.org/W3177091634, https://openalex.org/W2091901458, https://openalex.org/W2278818814, https://openalex.org/W2034803249, https://openalex.org/W2069424104, https://openalex.org/W2074758775, https://openalex.org/W2582890025, https://openalex.org/W2977381024, https://openalex.org/W2097691437, https://openalex.org/W2112451209, https://openalex.org/W2165714472, https://openalex.org/W2986831010, https://openalex.org/W2155826304, https://openalex.org/W3001909815, https://openalex.org/W134891189, https://openalex.org/W2035656939, https://openalex.org/W2409597399, https://openalex.org/W2736205323, https://openalex.org/W2133567486 |
| referenced_works_count | 41 |
| abstract_inverted_index.= | 208 |
| abstract_inverted_index.a | 8, 25, 112, 116, 242 |
| abstract_inverted_index.p | 207 |
| abstract_inverted_index.18 | 100 |
| abstract_inverted_index.2- | 26 |
| abstract_inverted_index.36 | 120 |
| abstract_inverted_index.82 | 183 |
| abstract_inverted_index.As | 273 |
| abstract_inverted_index.CD | 190, 200 |
| abstract_inverted_index.In | 248 |
| abstract_inverted_index.It | 60 |
| abstract_inverted_index.TE | 243, 257 |
| abstract_inverted_index.UC | 192, 213 |
| abstract_inverted_index.We | 43 |
| abstract_inverted_index.at | 111 |
| abstract_inverted_index.in | 30, 57, 77, 125, 189, 199, 219, 227, 260, 270, 282 |
| abstract_inverted_index.is | 5, 285 |
| abstract_inverted_index.of | 10, 33, 53, 102, 119, 127, 136, 146, 171, 222, 238, 278 |
| abstract_inverted_index.or | 104, 166, 169 |
| abstract_inverted_index.to | 27, 45, 65, 162, 266 |
| abstract_inverted_index.(67 | 180 |
| abstract_inverted_index.149 | 177 |
| abstract_inverted_index.IBD | 21, 58, 108, 128, 137, 178, 271 |
| abstract_inverted_index.TE, | 147, 163 |
| abstract_inverted_index.The | 95, 174, 215 |
| abstract_inverted_index.age | 103 |
| abstract_inverted_index.aim | 64 |
| abstract_inverted_index.and | 15, 50, 72, 75, 92, 109, 131, 143, 182, 191, 194, 252, 258 |
| abstract_inverted_index.did | 263 |
| abstract_inverted_index.due | 161 |
| abstract_inverted_index.for | 229, 256 |
| abstract_inverted_index.not | 264 |
| abstract_inverted_index.our | 63, 249 |
| abstract_inverted_index.the | 31, 39, 47, 51, 67, 220, 223, 230, 234, 239, 275 |
| abstract_inverted_index.was | 61, 87, 197 |
| abstract_inverted_index.(TE) | 56 |
| abstract_inverted_index.2016 | 91 |
| abstract_inverted_index.91.6 | 205 |
| abstract_inverted_index.ID). | 291 |
| abstract_inverted_index.This | 81 |
| abstract_inverted_index.also | 62 |
| abstract_inverted_index.have | 23 |
| abstract_inverted_index.none | 237 |
| abstract_inverted_index.only | 195 |
| abstract_inverted_index.rate | 158 |
| abstract_inverted_index.risk | 32, 254 |
| abstract_inverted_index.show | 265 |
| abstract_inverted_index.that | 20, 244 |
| abstract_inverted_index.this | 78, 283 |
| abstract_inverted_index.were | 123, 187, 218 |
| abstract_inverted_index.when | 36, 210 |
| abstract_inverted_index.with | 7, 38, 99, 107, 212 |
| abstract_inverted_index.(IBD) | 4 |
| abstract_inverted_index.2020. | 94 |
| abstract_inverted_index.April | 93 |
| abstract_inverted_index.Trial | 287 |
| abstract_inverted_index.[97.4 | 202 |
| abstract_inverted_index.about | 24 |
| abstract_inverted_index.bowel | 2 |
| abstract_inverted_index.fecal | 150 |
| abstract_inverted_index.males | 181 |
| abstract_inverted_index.range | 221 |
| abstract_inverted_index.study | 86, 175 |
| abstract_inverted_index.such, | 274 |
| abstract_inverted_index.terms | 126 |
| abstract_inverted_index.type, | 129 |
| abstract_inverted_index.years | 101 |
| abstract_inverted_index.(17.0) | 203 |
| abstract_inverted_index.(CRP), | 155 |
| abstract_inverted_index.(ESR), | 159 |
| abstract_inverted_index.3-fold | 28 |
| abstract_inverted_index.During | 233 |
| abstract_inverted_index.center | 83 |
| abstract_inverted_index.cohort | 96 |
| abstract_inverted_index.during | 115 |
| abstract_inverted_index.events | 55 |
| abstract_inverted_index.extent | 130 |
| abstract_inverted_index.family | 142 |
| abstract_inverted_index.older, | 105 |
| abstract_inverted_index.period | 118 |
| abstract_inverted_index.scores | 135 |
| abstract_inverted_index.single | 82 |
| abstract_inverted_index.study, | 250 |
| abstract_inverted_index.values | 217, 225 |
| abstract_inverted_index.venous | 16, 34 |
| abstract_inverted_index.versus | 204 |
| abstract_inverted_index.(13.3), | 206 |
| abstract_inverted_index.0.035], | 209 |
| abstract_inverted_index.between | 69, 89 |
| abstract_inverted_index.changes | 259 |
| abstract_inverted_index.disease | 3, 73, 132 |
| abstract_inverted_index.factors | 255 |
| abstract_inverted_index.general | 40 |
| abstract_inverted_index.history | 145 |
| abstract_inverted_index.levels, | 152 |
| abstract_inverted_index.months. | 121 |
| abstract_inverted_index.period, | 236 |
| abstract_inverted_index.protein | 154 |
| abstract_inverted_index.similar | 188 |
| abstract_inverted_index.smoking | 140 |
| abstract_inverted_index.variety | 9 |
| abstract_inverted_index.Methods: | 80 |
| abstract_inverted_index.November | 90 |
| abstract_inverted_index.Patients | 122 |
| abstract_inverted_index.Research | 18 |
| abstract_inverted_index.Results: | 173 |
| abstract_inverted_index.acquired | 251 |
| abstract_inverted_index.activity | 76 |
| abstract_inverted_index.arterial | 14 |
| abstract_inverted_index.clinical | 134, 276 |
| abstract_inverted_index.compared | 37 |
| abstract_inverted_index.demanded | 245 |
| abstract_inverted_index.evaluate | 46 |
| abstract_inverted_index.followed | 110 |
| abstract_inverted_index.history, | 141 |
| abstract_inverted_index.included | 97, 176 |
| abstract_inverted_index.increase | 29 |
| abstract_inverted_index.intended | 44 |
| abstract_inverted_index.patients | 22, 98, 179, 193, 201, 240 |
| abstract_inverted_index.personal | 144 |
| abstract_inverted_index.standard | 231 |
| abstract_inverted_index.surgery, | 167 |
| abstract_inverted_index.Registry: | 288 |
| abstract_inverted_index.activity, | 138 |
| abstract_inverted_index.behavior, | 133 |
| abstract_inverted_index.comparing | 211 |
| abstract_inverted_index.described | 226 |
| abstract_inverted_index.diagnosed | 106 |
| abstract_inverted_index.diagnosis | 170 |
| abstract_inverted_index.evaluated | 124 |
| abstract_inverted_index.evidences | 19 |
| abstract_inverted_index.females). | 184 |
| abstract_inverted_index.follow-up | 117, 235 |
| abstract_inverted_index.including | 13 |
| abstract_inverted_index.increased | 198 |
| abstract_inverted_index.influence | 267 |
| abstract_inverted_index.inherited | 253 |
| abstract_inverted_index.measuring | 279 |
| abstract_inverted_index.patients. | 59, 214, 272 |
| abstract_inverted_index.performed | 88 |
| abstract_inverted_index.phenotype | 74 |
| abstract_inverted_index.reference | 224 |
| abstract_inverted_index.relevance | 277 |
| abstract_inverted_index.C-reactive | 153 |
| abstract_inverted_index.associated | 6 |
| abstract_inverted_index.determined | 216 |
| abstract_inverted_index.literature | 228 |
| abstract_inverted_index.parameters | 49, 71, 186, 262, 281 |
| abstract_inverted_index.population | 284 |
| abstract_inverted_index.pregnancy, | 168 |
| abstract_inverted_index.prevalence | 52 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Coagulation | 185 |
| abstract_inverted_index.Conclusion: | 247 |
| abstract_inverted_index.IBD-related | 164 |
| abstract_inverted_index.NCT05162339 | 289 |
| abstract_inverted_index.Objectives: | 42 |
| abstract_inverted_index.coagulation | 48, 70, 148, 261, 280 |
| abstract_inverted_index.correlation | 68 |
| abstract_inverted_index.erythrocyte | 156 |
| abstract_inverted_index.experienced | 241 |
| abstract_inverted_index.investigate | 66 |
| abstract_inverted_index.malignancy. | 172 |
| abstract_inverted_index.medication, | 139 |
| abstract_inverted_index.parameters, | 149 |
| abstract_inverted_index.plasminogen | 196 |
| abstract_inverted_index.population. | 41, 79, 232 |
| abstract_inverted_index.prospective | 84 |
| abstract_inverted_index.Inflammatory | 1 |
| abstract_inverted_index.calprotectin | 151 |
| abstract_inverted_index.consultation, | 114 |
| abstract_inverted_index.observational | 85 |
| abstract_inverted_index.prothrombotic | 268 |
| abstract_inverted_index.questionable. | 286 |
| abstract_inverted_index.sedimentation | 157 |
| abstract_inverted_index.manifestations | 12 |
| abstract_inverted_index.predisposition | 269 |
| abstract_inverted_index.thromboembolic | 54 |
| abstract_inverted_index.extraintestinal | 11 |
| abstract_inverted_index.hospitalization | 160, 165 |
| abstract_inverted_index.thromboembolism | 35 |
| abstract_inverted_index.gastroenterology | 113 |
| abstract_inverted_index.hospitalization. | 246 |
| abstract_inverted_index.thromboembolism. | 17 |
| abstract_inverted_index.(ClinicalTrials.gov | 290 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.75524936 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |